Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at SurModics SRDX is 32.12%. SurModics had $28.43 million in total cash for the latest quarter. The trailing-twelve-month operating margin at Meridian Bioscience VIVO is 30.48%. Meridian Bioscience's ROE for the same period is 25.63%. The trailing-twelve-month operating margin at Trinity Biotech plc TRIB is 19.54%. Trinity Biotech's revenue for the same period is $86.08 million. The trailing-twelve-month operating margin at Quidel QDEL is 10.92%. Quidel's PEG ratio is 5.12.